Dr. Komal Jhaveri
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Breast Cancer
Studies Uterine Tumors
10 reported clinical trials
27 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 negative
ER positive
2Uterine Tumors
Stage III
Stage IV
HER2 negative
Affiliated Hospitals
Clinical Trials Komal Jhaveri is currently running
MEN2312
for Breast Cancer
This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer.
Recruiting1 award Phase 12 criteria
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
More about Komal Jhaveri
Clinical Trial Related1 year of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Komal Jhaveri has experience with
- Anastrozole
- Fulvestrant
- Abemaciclib
- Imlunestrant
- Exemestane
- Letrozole
Breakdown of trials Komal Jhaveri has run
Breast Cancer
Uterine Tumors
Endometrial Cancer
Stomach Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Komal Jhaveri specialize in?
Komal Jhaveri focuses on Breast Cancer and Uterine Tumors. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Komal Jhaveri currently recruiting for clinical trials?
Yes, Komal Jhaveri is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Komal Jhaveri has studied deeply?
Yes, Komal Jhaveri has studied treatments such as Anastrozole, Fulvestrant, Abemaciclib.
What is the best way to schedule an appointment with Komal Jhaveri?
Apply for one of the trials that Komal Jhaveri is conducting.
What is the office address of Komal Jhaveri?
The office of Komal Jhaveri is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.